A detailed history of Voya Investment Management LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 20,267 shares of ACET stock, worth $24,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,267
Holding current value
$24,523
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.76 - $3.45 $35,669 - $69,921
20,267 New
20,267 $47,000
Q2 2023

Aug 14, 2023

SELL
$2.13 - $7.13 $115,556 - $386,816
-54,252 Reduced 81.45%
12,359 $30,000
Q1 2023

May 15, 2023

SELL
$5.52 - $9.23 $302,827 - $506,357
-54,860 Reduced 45.16%
66,611 $383,000
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $1.49 Million - $2.08 Million
110,730 Added 1030.91%
121,471 $1.73 Million
Q2 2022

Aug 15, 2022

BUY
$10.26 - $20.81 $110,202 - $223,520
10,741 New
10,741 $157,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $48.4M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.